Well before he took office in January, Donald Trumps unorthodox means of communicating had drawn attention. Since his entering the White House last January, that attention has focused especially upon the mans fondness for Twitter.
Some celebrate Mr. Trumps use of social media as au courant a modern political figure must use modern modes of outreach, runs the thought. Others, by contrast, have experienced Mr. Trumps late night and early morning tweets with some consternation, declaring them out of synch with the dignity of the office of the Presidency of the United States.
I am, I confess, often among those who are at least somewhat nonplussed by Mr. Trumps tweets some of the time. I am unsure, however, whether it is the medium or the message that I have found jarring. Is it because Mr. Trump tweets at all that Im troubled, I wonder, or is it because of what he tweets? Or was Marshall McLuhan right in declaring that the medium is the message, such that the trouble heres both?
investment portfolio: Safeway Inc.(SWY)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:
- [By Peter Graham]
A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:
investment portfolio: Ebix, Inc.(EBIX)
Advisors’ Opinion:
- [By Peter Graham]
Small cap insurance software stock Ebix Inc (NASDAQ: EBIX) reported Q1 2017 earnings before the market opened this morning. Q1 revenue rose 11% to $79.1 million and decreased 1% over Q4 2016 revenue of $80.0 million. The year over year revenue improvement reflected growth in the Companys Exchange, Risk Compliance, and Broker Solution channels. On a constant currency basis, Q1 revenue increased 10% to $78.5 millionwith theExchange channel continued to bethe Companyslargest -accounting for 67% of Q1 2017 revenues. Q1 2017 net income rose 19% to $26.4 million with the improvement principally reflected the benefit of higher revenues and operating income as compared to the same period last year.
investment portfolio: Chimerix, Inc.(CMRX)
Advisors’ Opinion:
- [By WWW.MONEYSHOW.COM]
The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.
The drug is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adenovirus infection in allogeneic HCT patients.
investment portfolio: Capella Education Company(CPLA)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of Capella Education Company (NASDAQ: CPLA) got a boost, shooting up 32 percent to $86.60. Strayer Education Inc (NASDAQ: STRA) and Capella Education agreed to an all-stock merger. Capella Education also posted upbeat quarterly earnings.
investment portfolio: Jewett-Cameron Trading Company(JCTCF)
Advisors’ Opinion:
- [By Lisa Levin]
Jewett-Cameron Trading Company Ltd (NASDAQ: JCTCF) shares shot up 11 percent to $13.35. Jewett-Cameron reported Q3 earnings of $0.53 per share on revenue of $16.7 million.
